The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
 
Steven Francis Powell
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst)
 
Mark Mutuota Gitau
Research Funding - Merck Sharp & Dohme (Inst)
 
Christopher Joseph Sumey
Consulting or Advisory Role - Bristol-Myers Squibb
 
John T. Reynolds
No Relationships to Disclose
 
Michele Lohr
No Relationships to Disclose
 
Steven McGraw
No Relationships to Disclose
 
Ryan Kenneth Nowak
No Relationships to Disclose
 
Andrew M Terrell
Research Funding - Sanford Profile (Inst)
 
Ashley Wayne Jensen
No Relationships to Disclose
 
Miran Joel Blanchard
No Relationships to Disclose
 
Christie Ellison
No Relationships to Disclose
 
Lora Jane Black
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Paul A. Thompson
No Relationships to Disclose
 
Kathryn A. Gold
Honoraria - Roche/Genentech
Consulting or Advisory Role - ARIAD
Research Funding - ARIAD; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Pharmacyclics; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Human Longevity, Inc; Merck; Pfizer
Speakers' Bureau - Bayer; Eisai
 
John H. Lee
Employment - NantWorks
Leadership - NantWorks
 
William Charles Spanos
Consulting or Advisory Role - Merck